0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Colorectal Cancer Screening Market Insights, Forecast to 2029
Published Date: August 2023
|
Report Code: QYRE-Auto-31Y222
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Colorectal Cancer Screening Market Insights and Forecast to 2028
BUY CHAPTERS

Global Colorectal Cancer Screening Market Insights, Forecast to 2029

Code: QYRE-Auto-31Y222
Report
August 2023
Pages:112
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Colorectal Cancer Screening Market Size

The global Colorectal Cancer Screening market is projected to grow from US$ 680 million in 2023 to US$ 788.6 million by 2029, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period.

Colorectal Cancer Screening Market

Colorectal Cancer Screening Market

Colorectal cancer (CRC) is known as bowel cancer and colon cancer. It is the development of cancer from the colon or rectum. Screening for colorectal cancer can help prevent and treat the disease.
Market Analysis and Insights: Global Colorectal Cancer Screening Market
The US & Canada market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Colorectal Cancer Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Colorectal Cancer Screening include Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel and Siemens, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Colorectal Cancer Screening market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Colorectal Cancer Screening, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Colorectal Cancer Screening, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Colorectal Cancer Screening revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Colorectal Cancer Screening market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Colorectal Cancer Screening revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel and Siemens, etc.

Scope of Colorectal Cancer Screening Market Report

Report Metric Details
Report Name Colorectal Cancer Screening Market
Accounted market size in 2023 US$ 680 million
Forecasted market size in 2029 US$ 788.6 million
Base Year 2023
Forecasted years 2023 - 2029
Segment by Type
  • Stool-based Tests
  • Colonoscopy
  • CT Colonography
  • Others
Segment by Application
  • Hospitals
  • Independent Diagnostic Labs
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abbott, Clinical Genomics Technologies, Epigenomics Inc, Exact Sciences, Roche, Hemosure Inc, Novigenix SA, Quidel, Siemens, Sysmex
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Colorectal Cancer Screening in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Colorectal Cancer Screening companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America by type, by application and by country, revenue for each segment.
  • Chapter 7: Europe by type, by application and by country, revenue for each segment.
  • Chapter 8: China by type and by application revenue for each segment.
  • Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Colorectal Cancer Screening revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Stool-based Tests
1.2.3 Colonoscopy
1.2.4 CT Colonography
1.2.5 Others
1.3 Market by Application
1.3.1 Global Colorectal Cancer Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Independent Diagnostic Labs
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Screening Market Perspective (2018-2029)
2.2 Global Colorectal Cancer Screening Growth Trends by Region
2.2.1 Colorectal Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Colorectal Cancer Screening Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Screening Forecasted Market Size by Region (2024-2029)
2.3 Colorectal Cancer Screening Market Dynamics
2.3.1 Colorectal Cancer Screening Industry Trends
2.3.2 Colorectal Cancer Screening Market Drivers
2.3.3 Colorectal Cancer Screening Market Challenges
2.3.4 Colorectal Cancer Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Colorectal Cancer Screening by Players
3.1.1 Global Colorectal Cancer Screening Revenue by Players (2018-2023)
3.1.2 Global Colorectal Cancer Screening Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Colorectal Cancer Screening, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Colorectal Cancer Screening Market Concentration Ratio
3.4.1 Global Colorectal Cancer Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Screening Revenue in 2022
3.5 Global Key Players of Colorectal Cancer Screening Head office and Area Served
3.6 Global Key Players of Colorectal Cancer Screening, Product and Application
3.7 Global Key Players of Colorectal Cancer Screening, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Screening Breakdown Data by Type
4.1 Global Colorectal Cancer Screening Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Screening Forecasted Market Size by Type (2024-2029)
5 Colorectal Cancer Screening Breakdown Data by Application
5.1 Global Colorectal Cancer Screening Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Colorectal Cancer Screening Market Size (2018-2029)
6.2 North America Colorectal Cancer Screening Market Size by Type
6.2.1 North America Colorectal Cancer Screening Market Size by Type (2018-2023)
6.2.2 North America Colorectal Cancer Screening Market Size by Type (2024-2029)
6.2.3 North America Colorectal Cancer Screening Market Share by Type (2018-2029)
6.3 North America Colorectal Cancer Screening Market Size by Application
6.3.1 North America Colorectal Cancer Screening Market Size by Application (2018-2023)
6.3.2 North America Colorectal Cancer Screening Market Size by Application (2024-2029)
6.3.3 North America Colorectal Cancer Screening Market Share by Application (2018-2029)
6.4 North America Colorectal Cancer Screening Market Size by Country
6.4.1 North America Colorectal Cancer Screening Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Colorectal Cancer Screening Market Size by Country (2018-2023)
6.4.3 North America Colorectal Cancer Screening Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Colorectal Cancer Screening Market Size (2018-2029)
7.2 Europe Colorectal Cancer Screening Market Size by Type
7.2.1 Europe Colorectal Cancer Screening Market Size by Type (2018-2023)
7.2.2 Europe Colorectal Cancer Screening Market Size by Type (2024-2029)
7.2.3 Europe Colorectal Cancer Screening Market Share by Type (2018-2029)
7.3 Europe Colorectal Cancer Screening Market Size by Application
7.3.1 Europe Colorectal Cancer Screening Market Size by Application (2018-2023)
7.3.2 Europe Colorectal Cancer Screening Market Size by Application (2024-2029)
7.3.3 Europe Colorectal Cancer Screening Market Share by Application (2018-2029)
7.4 Europe Colorectal Cancer Screening Market Size by Country
7.4.1 Europe Colorectal Cancer Screening Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Colorectal Cancer Screening Market Size by Country (2018-2023)
7.4.3 Europe Colorectal Cancer Screening Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Colorectal Cancer Screening Market Size (2018-2029)
8.2 China Colorectal Cancer Screening Market Size by Type
8.2.1 China Colorectal Cancer Screening Market Size by Type (2018-2023)
8.2.2 China Colorectal Cancer Screening Market Size by Type (2024-2029)
8.2.3 China Colorectal Cancer Screening Market Share by Type (2018-2029)
8.3 China Colorectal Cancer Screening Market Size by Application
8.3.1 China Colorectal Cancer Screening Market Size by Application (2018-2023)
8.3.2 China Colorectal Cancer Screening Market Size by Application (2024-2029)
8.3.3 China Colorectal Cancer Screening Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Colorectal Cancer Screening Market Size (2018-2029)
9.2 Asia Colorectal Cancer Screening Market Size by Type
9.2.1 Asia Colorectal Cancer Screening Market Size by Type (2018-2023)
9.2.2 Asia Colorectal Cancer Screening Market Size by Type (2024-2029)
9.2.3 Asia Colorectal Cancer Screening Market Share by Type (2018-2029)
9.3 Asia Colorectal Cancer Screening Market Size by Application
9.3.1 Asia Colorectal Cancer Screening Market Size by Application (2018-2023)
9.3.2 Asia Colorectal Cancer Screening Market Size by Application (2024-2029)
9.3.3 Asia Colorectal Cancer Screening Market Share by Application (2018-2029)
9.4 Asia Colorectal Cancer Screening Market Size by Region
9.4.1 Asia Colorectal Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Colorectal Cancer Screening Market Size by Region (2018-2023)
9.4.3 Asia Colorectal Cancer Screening Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Type
10.2.1 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Application
10.3.1 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Country
10.4.1 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Colorectal Cancer Screening Introduction
11.1.4 Abbott Revenue in Colorectal Cancer Screening Business (2018-2023)
11.1.5 Abbott Recent Developments
11.2 Clinical Genomics Technologies
11.2.1 Clinical Genomics Technologies Company Details
11.2.2 Clinical Genomics Technologies Business Overview
11.2.3 Clinical Genomics Technologies Colorectal Cancer Screening Introduction
11.2.4 Clinical Genomics Technologies Revenue in Colorectal Cancer Screening Business (2018-2023)
11.2.5 Clinical Genomics Technologies Recent Developments
11.3 Epigenomics Inc
11.3.1 Epigenomics Inc Company Details
11.3.2 Epigenomics Inc Business Overview
11.3.3 Epigenomics Inc Colorectal Cancer Screening Introduction
11.3.4 Epigenomics Inc Revenue in Colorectal Cancer Screening Business (2018-2023)
11.3.5 Epigenomics Inc Recent Developments
11.4 Exact Sciences
11.4.1 Exact Sciences Company Details
11.4.2 Exact Sciences Business Overview
11.4.3 Exact Sciences Colorectal Cancer Screening Introduction
11.4.4 Exact Sciences Revenue in Colorectal Cancer Screening Business (2018-2023)
11.4.5 Exact Sciences Recent Developments
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Screening Introduction
11.5.4 Roche Revenue in Colorectal Cancer Screening Business (2018-2023)
11.5.5 Roche Recent Developments
11.6 Hemosure Inc
11.6.1 Hemosure Inc Company Details
11.6.2 Hemosure Inc Business Overview
11.6.3 Hemosure Inc Colorectal Cancer Screening Introduction
11.6.4 Hemosure Inc Revenue in Colorectal Cancer Screening Business (2018-2023)
11.6.5 Hemosure Inc Recent Developments
11.7 Novigenix SA
11.7.1 Novigenix SA Company Details
11.7.2 Novigenix SA Business Overview
11.7.3 Novigenix SA Colorectal Cancer Screening Introduction
11.7.4 Novigenix SA Revenue in Colorectal Cancer Screening Business (2018-2023)
11.7.5 Novigenix SA Recent Developments
11.8 Quidel
11.8.1 Quidel Company Details
11.8.2 Quidel Business Overview
11.8.3 Quidel Colorectal Cancer Screening Introduction
11.8.4 Quidel Revenue in Colorectal Cancer Screening Business (2018-2023)
11.8.5 Quidel Recent Developments
11.9 Siemens
11.9.1 Siemens Company Details
11.9.2 Siemens Business Overview
11.9.3 Siemens Colorectal Cancer Screening Introduction
11.9.4 Siemens Revenue in Colorectal Cancer Screening Business (2018-2023)
11.9.5 Siemens Recent Developments
11.10 Sysmex
11.10.1 Sysmex Company Details
11.10.2 Sysmex Business Overview
11.10.3 Sysmex Colorectal Cancer Screening Introduction
11.10.4 Sysmex Revenue in Colorectal Cancer Screening Business (2018-2023)
11.10.5 Sysmex Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Colorectal Cancer Screening Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
    Table 2. Key Players of Stool-based Tests
    Table 3. Key Players of Colonoscopy
    Table 4. Key Players of CT Colonography
    Table 5. Key Players of Others
    Table 6. Global Colorectal Cancer Screening Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
    Table 7. Global Colorectal Cancer Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Colorectal Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
    Table 9. Global Colorectal Cancer Screening Market Share by Region (2018-2023)
    Table 10. Global Colorectal Cancer Screening Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 11. Global Colorectal Cancer Screening Market Share by Region (2024-2029)
    Table 12. Colorectal Cancer Screening Market Trends
    Table 13. Colorectal Cancer Screening Market Drivers
    Table 14. Colorectal Cancer Screening Market Challenges
    Table 15. Colorectal Cancer Screening Market Restraints
    Table 16. Global Colorectal Cancer Screening Revenue by Players (2018-2023) & (US$ Million)
    Table 17. Global Colorectal Cancer Screening Revenue Share by Players (2018-2023)
    Table 18. Global Top Colorectal Cancer Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Screening as of 2022)
    Table 19. Global Colorectal Cancer Screening Industry Ranking 2021 VS 2022 VS 2023
    Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Screening Revenue (CR5 and HHI) & (2018-2023)
    Table 21. Global Key Players of Colorectal Cancer Screening, Headquarters and Area Served
    Table 22. Global Key Players of Colorectal Cancer Screening, Product and Application
    Table 23. Global Key Players of Colorectal Cancer Screening, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Colorectal Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Global Colorectal Cancer Screening Revenue Market Share by Type (2018-2023)
    Table 27. Global Colorectal Cancer Screening Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 28. Global Colorectal Cancer Screening Revenue Market Share by Type (2024-2029)
    Table 29. Global Colorectal Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
    Table 30. Global Colorectal Cancer Screening Revenue Share by Application (2018-2023)
    Table 31. Global Colorectal Cancer Screening Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 32. Global Colorectal Cancer Screening Revenue Share by Application (2024-2029)
    Table 33. North America Colorectal Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
    Table 34. North America Colorectal Cancer Screening Market Size by Type (2024-2029) & (US$ Million)
    Table 35. North America Colorectal Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
    Table 36. North America Colorectal Cancer Screening Market Size by Application (2024-2029) & (US$ Million)
    Table 37. North America Colorectal Cancer Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. North America Colorectal Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
    Table 39. North America Colorectal Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Europe Colorectal Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
    Table 41. Europe Colorectal Cancer Screening Market Size by Type (2024-2029) & (US$ Million)
    Table 42. Europe Colorectal Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
    Table 43. Europe Colorectal Cancer Screening Market Size by Application (2024-2029) & (US$ Million)
    Table 44. Europe Colorectal Cancer Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Europe Colorectal Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Europe Colorectal Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
    Table 47. China Colorectal Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
    Table 48. China Colorectal Cancer Screening Market Size by Type (2024-2029) & (US$ Million)
    Table 49. China Colorectal Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
    Table 50. China Colorectal Cancer Screening Market Size by Application (2024-2029) & (US$ Million)
    Table 51. Asia Colorectal Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
    Table 52. Asia Colorectal Cancer Screening Market Size by Type (2024-2029) & (US$ Million)
    Table 53. Asia Colorectal Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
    Table 54. Asia Colorectal Cancer Screening Market Size by Application (2024-2029) & (US$ Million)
    Table 55. Asia Colorectal Cancer Screening Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 56. Asia Colorectal Cancer Screening Market Size by Region (2018-2023) & (US$ Million)
    Table 57. Asia Colorectal Cancer Screening Market Size by Region (2024-2029) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Type (2018-2023) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Type (2024-2029) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Application (2018-2023) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Application (2024-2029) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Colorectal Cancer Screening Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 63. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Country (2018-2023) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size by Country (2024-2029) & (US$ Million)
    Table 65. Abbott Company Details
    Table 66. Abbott Business Overview
    Table 67. Abbott Colorectal Cancer Screening Product
    Table 68. Abbott Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 69. Abbott Recent Developments
    Table 70. Clinical Genomics Technologies Company Details
    Table 71. Clinical Genomics Technologies Business Overview
    Table 72. Clinical Genomics Technologies Colorectal Cancer Screening Product
    Table 73. Clinical Genomics Technologies Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 74. Clinical Genomics Technologies Recent Developments
    Table 75. Epigenomics Inc Company Details
    Table 76. Epigenomics Inc Business Overview
    Table 77. Epigenomics Inc Colorectal Cancer Screening Product
    Table 78. Epigenomics Inc Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 79. Epigenomics Inc Recent Developments
    Table 80. Exact Sciences Company Details
    Table 81. Exact Sciences Business Overview
    Table 82. Exact Sciences Colorectal Cancer Screening Product
    Table 83. Exact Sciences Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 84. Exact Sciences Recent Developments
    Table 85. Roche Company Details
    Table 86. Roche Business Overview
    Table 87. Roche Colorectal Cancer Screening Product
    Table 88. Roche Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 89. Roche Recent Developments
    Table 90. Hemosure Inc Company Details
    Table 91. Hemosure Inc Business Overview
    Table 92. Hemosure Inc Colorectal Cancer Screening Product
    Table 93. Hemosure Inc Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 94. Hemosure Inc Recent Developments
    Table 95. Novigenix SA Company Details
    Table 96. Novigenix SA Business Overview
    Table 97. Novigenix SA Colorectal Cancer Screening Product
    Table 98. Novigenix SA Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 99. Novigenix SA Recent Developments
    Table 100. Quidel Company Details
    Table 101. Quidel Business Overview
    Table 102. Quidel Colorectal Cancer Screening Product
    Table 103. Quidel Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 104. Quidel Recent Developments
    Table 105. Siemens Company Details
    Table 106. Siemens Business Overview
    Table 107. Siemens Colorectal Cancer Screening Product
    Table 108. Siemens Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 109. Siemens Recent Developments
    Table 110. Sysmex Company Details
    Table 111. Sysmex Business Overview
    Table 112. Sysmex Colorectal Cancer Screening Product
    Table 113. Sysmex Revenue in Colorectal Cancer Screening Business (2018-2023) & (US$ Million)
    Table 114. Sysmex Recent Developments
    Table 115. Research Programs/Design for This Report
    Table 116. Key Data Information from Secondary Sources
    Table 117. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Colorectal Cancer Screening Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 2. Global Colorectal Cancer Screening Market Share by Type: 2022 VS 2029
    Figure 3. Stool-based Tests Features
    Figure 4. Colonoscopy Features
    Figure 5. CT Colonography Features
    Figure 6. Others Features
    Figure 7. Global Colorectal Cancer Screening Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 8. Global Colorectal Cancer Screening Market Share by Application: 2022 VS 2029
    Figure 9. Hospitals Case Studies
    Figure 10. Independent Diagnostic Labs Case Studies
    Figure 11. Others Case Studies
    Figure 12. Colorectal Cancer Screening Report Years Considered
    Figure 13. Global Colorectal Cancer Screening Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Colorectal Cancer Screening Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Colorectal Cancer Screening Market Share by Region: 2022 VS 2029
    Figure 16. Global Colorectal Cancer Screening Market Share by Players in 2022
    Figure 17. Global Top Colorectal Cancer Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Screening as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Colorectal Cancer Screening Revenue in 2022
    Figure 19. North America Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Colorectal Cancer Screening Market Share by Type (2018-2029)
    Figure 21. North America Colorectal Cancer Screening Market Share by Application (2018-2029)
    Figure 22. North America Colorectal Cancer Screening Market Share by Country (2018-2029)
    Figure 23. United States Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Colorectal Cancer Screening Market Size YoY (2018-2029) & (US$ Million)
    Figure 26. Europe Colorectal Cancer Screening Market Share by Type (2018-2029)
    Figure 27. Europe Colorectal Cancer Screening Market Share by Application (2018-2029)
    Figure 28. Europe Colorectal Cancer Screening Market Share by Country (2018-2029)
    Figure 29. Germany Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. France Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. U.K. Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Italy Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Russia Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Nordic Countries Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. China Colorectal Cancer Screening Market Size YoY (2018-2029) & (US$ Million)
    Figure 36. China Colorectal Cancer Screening Market Share by Type (2018-2029)
    Figure 37. China Colorectal Cancer Screening Market Share by Application (2018-2029)
    Figure 38. Asia Colorectal Cancer Screening Market Size YoY (2018-2029) & (US$ Million)
    Figure 39. Asia Colorectal Cancer Screening Market Share by Type (2018-2029)
    Figure 40. Asia Colorectal Cancer Screening Market Share by Application (2018-2029)
    Figure 41. Asia Colorectal Cancer Screening Market Share by Region (2018-2029)
    Figure 42. Japan Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. South Korea Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. China Taiwan Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Southeast Asia Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. India Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Australia Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Size YoY (2018-2029) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Share by Type (2018-2029)
    Figure 50. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Share by Application (2018-2029)
    Figure 51. Middle East, Africa, and Latin America Colorectal Cancer Screening Market Share by Country (2018-2029)
    Figure 52. Brazil Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 53. Mexico Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 54. Turkey Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 55. Saudi Arabia Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 56. Israel Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 57. GCC Countries Colorectal Cancer Screening Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 58. Abbott Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 59. Clinical Genomics Technologies Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 60. Epigenomics Inc Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 61. Exact Sciences Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 62. Roche Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 63. Hemosure Inc Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 64. Novigenix SA Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 65. Quidel Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 66. Siemens Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 67. Sysmex Revenue Growth Rate in Colorectal Cancer Screening Business (2018-2023)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS